Logistics was Strata Critical Medical’s largest segment in fiscal 2025, bringing in $530.38M of $564.53M (94%).
| Segment | FY 2021 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|
| Logistics | — | — | $440.45M | $530.38M | ||
| Medical | $215.34M | $379.81M | — | — | ||
| Passenger | $223.02M | $212.10M | — | — | ||
| Clinical | — | — | — | $34.15M | ||
| Total | $438.36M | $591.91M | $440.45M | $564.53M |
Strata Critical Medical brought in $564.53M from its two segments in fiscal 2025, the year ended December 31, 2025. Strata Critical Medical regrouped these segments after fiscal 2024, so the total does not compare directly with that year's $440.45M. Logistics was the largest at $530.38M (94.0%), ahead of Clinical at $34.15M (6.0%).
Strata Critical Medical began breaking out Logistics in fiscal 2024 and Clinical in fiscal 2025. Strata Critical Medical stopped reporting Medical ($379.81M in fiscal 2023) and Passenger ($212.10M in fiscal 2023) as separate segments.
Medimobility Organ Transport was Strata Critical Medical’s largest product and service line in fiscal 2023, bringing in $379.81M of $675.54M (56%).
| Product and Service | FY 2019 | FY 2020 | FY 2021 | FY 2021 | FY 2022 | FY 2023 |
|---|---|---|---|---|---|---|
| Medimobility Organ Transport | — | $19.20M | $29.47M | $215.34M | $379.81M | |
| Medimobility Organ Transport & Jet | $40.43M | — | — | — | — | |
| Short Distance | $28.40M | $67.39M | $18.77M | $134.96M | $212.10M | |
| Jet & Other | — | $64.99M | $25.62M | $88.07M | $83.63M | |
| Other | $1.48M | — | — | — | — | |
| Total | $70.30M | $151.58M | $73.85M | $438.36M | $675.54M |
Strata Critical Medical brought in $675.54M from its three product and service lines in fiscal 2023, the year ended December 31, 2023. That was up 54.1% from $438.36M in fiscal 2022. Medimobility Organ Transport was the largest at $379.81M (56.2%), ahead of Short Distance at $212.10M (31.4%) and Jet & Other at $83.63M (12.4%).
Compared with fiscal 2022, Medimobility Organ Transport grew fastest, up 76.4% to $379.81M, while Jet & Other fell the most, down 5.0% to $83.63M.
Strata Critical Medical began breaking out Medimobility Organ Transport in fiscal 2021 and Jet & Other in fiscal 2021. Strata Critical Medical stopped reporting Medimobility Organ Transport & Jet ($40.43M in fiscal 2020) and Other ($1.48M in fiscal 2020) as separate lines.
United States was Strata Critical Medical’s largest region in fiscal 2023, bringing in $572.23M of $675.54M (85%).
| Geography | FY 2021 | FY 2021 | FY 2022 | FY 2023 |
|---|---|---|---|---|
| United States | $151.58M | $71.79M | $399.89M | $572.23M |
| Other | — | $2.07M | $38.47M | $103.31M |
| Total | $151.58M | $73.85M | $438.36M | $675.54M |
Strata Critical Medical brought in $675.54M from its two regions in fiscal 2023, the year ended December 31, 2023. That was up 54.1% from $438.36M in fiscal 2022. United States was the largest at $572.23M (84.7%), ahead of Other at $103.31M (15.3%).
Compared with fiscal 2022, Other grew 168.6% to $103.31M and United States grew 43.1% to $572.23M.
Strata Critical Medical (SRTA) reports its revenue by segment, by product and service and by geography. In fiscal 2025, Logistics was its largest segment, bringing in $530.38M (94.0% of the total), followed by Clinical at $34.15M (6.0%).
Logistics was Strata Critical Medical's largest segment in fiscal 2025, bringing in $530.38M, or 94.0% of the $564.53M total across its two segments.
Medimobility Organ Transport was Strata Critical Medical's largest product and service line in fiscal 2023, bringing in $379.81M, or 56.2% of the $675.54M total across its three product and service lines.
United States was Strata Critical Medical's largest region in fiscal 2023, bringing in $572.23M, or 84.7% of the $675.54M total across its two regions.
Among Strata Critical Medical's product and service lines that make up at least 2% of revenue, Medimobility Organ Transport grew fastest in fiscal 2023, up 76.4% from $215.34M to $379.81M.
Every figure comes from Strata Critical Medical's annual financial filings, as reported. Each line keeps the name Strata Critical Medical gives it, and years follow its fiscal calendar.
Strata Critical Medical's revenue by segment goes back to fiscal 2021, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.